Cannabis and PTSD: High Hopes or Just Hype?

The use of cannabis and synthetic cannabinoids in managing post-traumatic stress disorder (PTSD) has garnered significant interest due to their potential therapeutic benefits and associated risks. PTSD is a debilitating psychiatric condition. It is marked by symptoms like hyperarousal, anxiety, depressive symptoms, and sleep disturbances, often following a traumatic event. Traditional treatments include pharmacological interventions like selective serotonin reuptake inhibitors (SSRIs) and psychological therapies. However, there is growing interest in cannabis and synthetic cannabinoids as alternative treatments.

Exploring the Benefits of Cannabis Use for Managing PTSD Symptoms

1. Symptom Relief: Medical cannabis users have reported improvements in sleep quality and reductions in anxiety and hyperarousal symptoms. Tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, has been noted for its potential to alleviate intrusive symptoms, hyperarousal, avoidance, and numbing. Cannabidiol (CBD), a non-psychotomimetic cannabinoid, has shown promise in reducing PTSD severity and intensity. Studies report significant reductions in symptom severity and improvements in sleep quality.

2. Sleep Improvement: Research conducted in the UK has observed significant improvements in sleep quality, anxiety, and PTSD-specific symptoms (intrusions, avoidance, and hyperarousal) among patients prescribed medical cannabis. Another study from Israel found that the closer to bedtime an individual used cannabis, the less likely they were to experience nightmares, which may translate to reduced daytime stress. Additionally, those who used products with higher CBD concentrations reported fewer early awakenings and longer sleep durations.

3. Reduction in Nightmares: Synthetic cannabinoids like Nabilone have demonstrated efficacy in reducing nightmares, improving sleep, and alleviating PTSD symptoms. Studies have shown that Nabilone significantly reduces the presence and intensity of nightmares, increases hours of sleep per night, and improves overall PTSD symptoms.

4. Improvement in Quality of Life: Cannabis has demonstrated efficacy in improving functional outcomes such as social function, family function, and quality of life. Several studies reported that cannabis use significantly improved these aspects, contributing to better overall functioning and well-being. For instance, medical cannabis use was associated with significant improvement in social and family life, including marital relationships and parent-child interactions.

5. Reduction in Alcohol Use: Survey data indicated that 80% of respondents reported consuming less alcohol when using cannabis, suggesting that cannabis may help reduce alcohol use problems commonly associated with PTSD. This finding challenges the notion that marijuana is a "gateway" drug and suggests that it may have a role in harm reduction.

6. Veteran Benefits: Veterans, who comprised a significant portion of survey respondents, reported being prescribed more medications than civilians and were more likely to receive medications that generally worsened symptoms. Veterans also reported higher rates of alcohol problems. The survey highlighted that veterans might benefit significantly from cannabis therapy, given the high prevalence of PTSD and the limited effectiveness of conventional treatments. Yet, the VA does not recommend it as part of treatment for PTSD.

Exploring the Potential Risks of Using Cannabis to Treat PTSD Symptoms

Despite these positive findings, it is also important to consider the potential adverse effects associated with cannabis use.

1. Dependence and Cognitive Dysfunction: Chronic use of cannabis can lead to dependence and cognitive dysfunction. The risk of developing cannabis use disorder (CUD) is significant, particularly among individuals using cannabis to manage PTSD symptoms. This can result in reduced endogenous cannabinoid functioning due to global cortical downregulation of CB1 receptor availability.

2. Increased PTSD Symptoms: Not all cannabis research has been positive. One study found that PTSD symptoms were increased in those who used alcohol, heroin, cocaine, and cannabis. Despite validated assessments indicating worsening PTSD symptoms, participants reported feeling the substances improved symptoms.

3. Suicidal Ideation and Attempts: Authors of another study found that Iraq/Afghanistan-era veterans who met criteria for cannabis use disorder had 1.7 times higher current suicidal ideation and 2.3 times higher lifetime suicide attempts compared to those who did not meet criteria.

4. Impairment in Treatment Engagement: Cannabis use may impair engagement with evidence-based treatments and exacerbate PTSD symptoms during treatment. Research involving veterans undergoing intensive outpatient therapy found no significant difference in treatment success between cannabis users and non-users, suggesting that cannabis use does not enhance treatment outcomes. However, VA-funded studies have shown biased attitudes towards cannabis use alongside low-quality studies to accommodate for confounding factors.

Confounding Factors

Some studies have been considered low quality due to the inability to determine the quantity or quality of cannabis used by veterans in the cannabis use group, as this information was often missing from chart reviews. Additionally, specific composition and concentrations of cannabinoids (e.g., THC, CBD) in cannabis used could not be determined, and these differences may have impacted results.

Conclusion

Overall, while cannabis and synthetic cannabinoids show promise in managing PTSD symptoms, the current evidence remains limited and mixed. More rigorous randomized controlled trials with larger sample sizes are needed to better understand the long-term effects and safety of these treatments. Clinicians should carefully weigh the potential therapeutic benefits against the risks and consider all available treatment options, including traditional pharmacological and psychological interventions. These findings highlight the importance of personalized treatment plans and continuous monitoring to optimize outcomes for individuals with PTSD.

As research continues to evolve, a balanced and informed approach remains essential in integrating cannabis into PTSD treatment. By prioritizing individualized care, evidence-based guidance, and ongoing support, patients and clinicians can work together to achieve the best possible outcomes in symptom management and overall well-being.

Citations:

1. Orsolini, L., Chiappini, S., Volpe, U., De Berardis, D., Latini, R., Papanti, G. D., & Corkery, J. M. (2019). Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review. , 55(9), 525. [https://doi.org/10.3390/medicina55090525](https://doi.org/10.3390/medicina55090525)

2. LaFrance, E. M., Glodosky, N. C., Bonn-Miller, M., & Cuttler, C. (2020). Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder. , , 420-427. [https://doi.org/10.1016/j.jad.2020.05.132](https://doi.org/10.1016/j.jad.2020.05.132)

3. Rehman, Y., Saini, A., Huang, S., Sood, E., Gill, R., & Yanikomeroglu, S. (2021). Cannabis in the management of PTSD: A systematic review. (3), 414–434. [https://doi.org/10.3934/Neuroscience.2021022](https://doi.org/10.3934/Neuroscience.2021022)

4. Petersen, M., Koller, K., Straley, C., & Reed, E. (2021). Effect of cannabis use on PTSD treatment outcomes in veterans. , 11(4), 238-242. [https://doi.org/10.9740/mhc.2021.07.238](https://doi.org/10.9740/mhc.2021.07.238)

5. Bedard-Gilligan, M., Lehinger, E., Cornell-Maier, S., Holloway, A., & Zoellner, L. (2022). Effects of cannabis on PTSD recovery: Review of the literature and clinical insights. , (3), 203–216. [https://doi.org/10.1007/s40429-022-00414-x](https://doi.org/10.1007/s40429-022-00414-x)

6. Metrik, J., Stevens, A. K., Gunn, R. L., Borsari, B., & Jackson, K. M. (2022). Cannabis use and posttraumatic stress disorder: Prospective evidence from a longitudinal study of veterans. (3), 446–456. [https://doi.org/10.1017/S003329172000197X](https://doi.org/10.1017/S003329172000197X)

7. Care By Design. (2016, March 16). PTSD Patient Survey. Care By Design.

8. Hill, M., Kline, A. C., Saraiya, T. C., Gette, J., Ruglass, L. M., Norman, S. B., Back, S. E., Saavedra, L. M., Hien, D. A., & Morgan-López, A. A. (2024). Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data. [https://doi.org/10.1016/j.janxdis.2024.102456](https://doi.org/10.1016/j.janxdis.2024.102456)

9. Norman, S. B., Haller, M., Hamblen, J. L., Southwick, S. M., & Pietrzak, R. H. (2019). Trauma-focused and non-trauma-focused treatment for PTSD and alcohol use disorder: A comparison of attendance and treatment outcomes. , 75(9), 1585-1598. [https://doi.org/10.1002/jclp.22823](https://doi.org/10.1002/jclp.22823)

10. Noel. (2023, May 22). Three new studies on cannabis and PTSD | Project CBD. *Project CBD*. [https://projectcbd.org/health/new-studies-cannabis-ptsd/](https://projectcbd.org/health/new-studies-cannabis-ptsd/)

11. *[VA.gov](http://VA.gov)** | Veterans Affairs*. (n.d.). [https://www.ptsd.va.gov/professional/treat/cooccurring/marijuana_ptsd_vets.asp](https://www.ptsd.va.gov/professional/treat/cooccurring/marijuana_ptsd_vets.asp)